Showing results (121-130 of 224) with videos related to
Sort By:
Pageof 23
Kidney International|June 2, 2020
Artificial intelligence and machine learning in nephropathologyJan U Becker, David Mayerich, Meghana Padmanabhan, et al.Clinical Kidney Journal|August 11, 2018
Study protocol: responding to the needs of patients with IgA nephropathy, a social media approachMatthew P M Graham-Brown, Cristina Vasilica, Tom Oates, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 8, 2012
Spleen tyrosine kinase is important in the production of proinflammatory cytokines and cell proliferation in human mesangial cells following stimulation with IgA1 isolated from IgA nephropathy patientsMin Jeong Kim, John P McDaid, Stephen P McAdoo, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 14, 2020
Relationship between immunoglobulin A1 lectin-binding specificities, mesangial C4d deposits and clinical phenotypes in immunoglobulin A nephropathyAlfons Segarra Medrano, Andrea Muijsemberg, David Wimbury, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 12, 2022
Rapidly progressive IgA nephropathy: clinicopathological characteristics and outcomes assessed according to the revised definition of the KDIGO 2021 GuidelineBingxin Yu, Sufang Shi, Jicheng Lv, et al.Kidney International|May 1, 2022
Application of the International IgA Nephropathy Prediction Tool one or two years post-biopsySean J Barbour, Rosanna Coppo, Hong Zhang, et al.Kidney International Reports|November 29, 2023
Targeting the Endothelin A Receptor in IgA NephropathyDonald E Kohan, Jonathan Barratt, Hiddo J L Heerspink, et al.Nephron. Experimental Nephrology|February 28, 2004
Inhibitors directed towards caspase-1 and -3 are less effective than pan caspase inhibition in preventing renal proximal tubular cell apoptosisBin Yang, A Meguid El Nahas, Marie Fisher, et al.Kidney International|March 27, 2026
Complement inhibitors and B-cell modifying agents for IgA nephropathy- a KDIGO commentaryBrad H Rovin, Jonathan Barratt, H Terence Cook, et al.Kidney International Reports|July 13, 2026
Characterization of Patient-Reported Loin Pain in IgANKristina L Newman, Jonathan Barratt, Justyna Szklarzewicz, et al.Pageof 23